BIROn - Birkbeck Institutional Research Online

    Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A

    Hart, D.P. and Uzun, Nazmiye and Skelton, S. and Kakoschke, A. and Househam, J. and Moss, David S. and Shepherd, Adrian J. (2018) Factor VIII cross-matches to the human proteome reduce the predicted inhibitor risk in missense mutation hemophilia A. Haematologica 103 (10), ISSN 0390-6078.

    [img] Text
    24071.pdf - Author's Accepted Manuscript
    Restricted to Repository staff only

    Download (409kB) | Request a copy
    24071a.pdf - Published Version of Record
    Available under License Creative Commons Attribution.

    Download (4MB) | Preview


    Single missense mutations in the F8 gene encoding the coagulation protein factor VIII (FVIII) give rise predominantly to non-severe hemophilia A. Despite only a single amino acid sequence difference between the replacement, therapeutic FVIII (tFVIII) and the patient’s endogenous FVIII, tFVIII may still be perceived as foreign by the recipient’s immune system and trigger an immune response (inhibitor). Inhibitor formation is a life-long risk for non-severe hemophilia A patients treated with tFVIII, but remains difficult to predict. The aim of this study was to understand whether fortuitous, primary sequence cross-matches between tFVIII and proteins in the human proteome are the reason why certain F8 mutations are not associated with inhibitor formation. We predicted which tFVIII differences are potentially perceived as foreign by helper T cells – a necessary precursor to inhibitor development – and then scanned potentially immunogenic peptides against more than 100,000 proteins in the proteome. As there are hundreds of disease-causing F8 missense mutations and the Human Leucocyte Antigen gene complex governing peptide presentation to helper T cells is highly polymorphic, these calculations pose a huge combinatorial challenge that we addressed computationally. We identify that cross-matches between tFVIII and the human proteome are commonplace and have a profound impact on the predicted risk of inhibitor development. Our results emphasize the importance of knowing both the F8 missense mutation and the Human Leucocyte Antigen alleles of a patient with missense mutation hemophilia A if his underlying risk of inhibitor development is to be estimated.


    Item Type: Article
    Keyword(s) / Subject(s): haemophilia, proteome, Factor VIII, Human Leucocyte Antigens
    School: Birkbeck Faculties and Schools > Faculty of Science > School of Natural Sciences
    Research Centres and Institutes: Data Analytics, Birkbeck Institute for
    Depositing User: Adrian Shepherd
    Date Deposited: 03 Oct 2018 10:19
    Last Modified: 02 Aug 2023 17:44


    Activity Overview
    6 month trend
    6 month trend

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item